White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study

Oliver, S.E., Gunnell, D., Donovan, J., Peters, T.J., Persad, R., Gillatt, D., Pearce, A., Neal, D.E., Hamdy, F.C. and Holly, J. (2003) Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. International Journal of Cancer, 108 (6). pp. 887-892. ISSN 0020-7136

Full text not available from this repository.

Abstract

Higher circulating levels of IGF-I have been associated with increased risk of prostate and some other cancers. Most research on prostate cancer has been based on men with symptoms or identified following treatment of benign disease. However, increasing numbers of cancer cases are now detected in asymptomatic men following prostate-specific antigen (PSA) tests. We therefore used a population-based case-finding exercise using the PSA test to examine whether associations between the IGF axis and cancer risk were apparent in this population. A matched case-control study was conducted among 7,383 men (50-70 years) receiving a PSA test as part of a case-finding exercise. Assays of IGF-I, IGF-II, IGFBP-2 and IGFBP-3 were performed on cases and 2 controls matched on age, recruitment center and calendar time. Analyses were based on 176 cases and 324 matched controls. The risk of prostate cancer increased across quartiles of IGF-I (highest vs. lowest quartile, OR = 2.34; 95% CI = 1.26-4.34; ptrend = 0.02) and IGF-II (OR = 1.78; 95% CI = 0.94-3.15; ptrend = 0.09). Controlling for smoking history and IGFBP-3 strengthened associations with cancer for both IGF-I (OR = 3.00; 95% CI = 1.50-6.01; ptrend 0.005) and IGF-II (OR = 2.02; 95% CI = 1.07-3.84; ptrend = 0.04) Associations between the IGFs and cancer risk were stronger for advanced cases. Our findings suggest that both IGF-I and IGF-II are associated with an increased risk of screen-detected prostate cancer.

Item Type: Article
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield)
The University of York > Hull York Medical School (York)
The University of York > Health Sciences (York)
Depositing User: York RAE Import
Date Deposited: 15 May 2009 10:54
Last Modified: 15 May 2009 10:54
Published Version: http://dx.doi.org/10.1002/ijc.11631
Status: Published
Publisher: John Wiley & Sons, Ltd
Identification Number: 10.1002/ijc.11631
URI: http://eprints.whiterose.ac.uk/id/eprint/6370

Actions (login required)

View Item View Item